Log In
Print
BCIQ
Print
Print this Print this
 

Recothrom (formerly rThrombin)

Also known as: formerly rhThrombin

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionRecombinant human thrombin
Molecular Target Fibrinogen
Mechanism of ActionCoagulant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsControl blood loss at excision site during skin graft surgery; Control blood loss during surgery; Control blood loss in pediatric patients undergoing synchronous burn wound excision and skin grafting
Regulatory Designation
Partner The Medicines Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,000.0M

$1,000.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today